J--Illumina Services

This contract, issued by the Department of the Interior's Interior Business Center Acquisition Services Directorate on behalf of the National Institutes of Health, National Cancer Institute, is a firm-fixed-price solicitation for maintenance and service support of various government-owned Illumina sequencing platforms and related ancillary equipment located onsite at NIH facilities in Rockville, Maryland. The services include professional repair, routine maintenance, and software updates for sequencing instruments such as NextSeq2000 and iScan systems. The Contractor must provide 24/7 technical support, ensure compliance with original equipment manufacturer standards, and maintain a clean working environment. The contract term covers a 12-month base period with one 12-month option period, and the award will be based solely on the lowest priced, technically acceptable proposal. Key contract requirements include strict adherence to Section 508 accessibility standards for all digital deliverables, and reporting and correction of any non-compliance at the Contractor's expense. Software updates require prior Government approval, and defective software must be replaced at no extra cost. Emergency response demands the Contractor respond within one hour of notification and dispatch technicians within 48 hours, using OEM or certified replacement parts delivered within 24 hours where possible. Contractor personnel must be OEM-trained and authorized, with backup staff to ensure seamless service continuity. Invoicing is conducted electronically through the U.S. Treasury’s Invoice Processing Platform, with payment via the System for Award Management. The Government retains exclusive acceptance authority, with inspections performed at the NIH site according to accessibility and technical standards mandated by federal regulations. Pricing is to be proposed by offerors for both base and option periods, and socio-economic set-asides do not apply. Contracting Officer Bridgette Ornelas is the primary contact for the solicitation, which imposes no packaging or marking requirements, no travel reimbursement beyond fixed pricing, and includes anti-lobbying restrictions consistent with HHS acquisition regulations.